Henk Codrington

782 citations

20 papers · 587 · h-index 11

Impact in

Geriatrics and Gerontology top 5%
- Frailty in Older Adults
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations

Papers in

Pulmonary and Respiratory Medicine 15
- Lung Cancer Treatments and Mutations 12
- Lung Cancer Diagnosis and Treatment 9
- Tracheal and airway disorders 2
Oncology 11
- Colorectal Cancer Treatments and Studies 6
- Lung Cancer Research Studies 6

Co-authors: Joachim G.J.V. Aerts (6 shared papers)Harm van Tinteren (3 shared papers)Renée van Pel (3 shared papers)Renato A. Valdés Olmos (3 shared papers)Houke M. Klomp (3 shared papers)Ingrid Kappers (2 shared papers)Elle K.J. Risse (2 shared papers)Richard P. Golding (2 shared papers)
Journals: Journal of Clinical Oncology (5 papers)Radiotherapy and Oncology (3 papers)Lung Cancer (2 papers)Annals of Oncology (2 papers)Journal of Nuclear Medicine (1 paper)
Partner nations: Netherlands United States Malaysia

In The Last Decade

Henk Codrington

20 papers receiving 575 citations

Peers

Countries citing papers authored by Henk Codrington

Since Specialization

Citations

This map shows the geographic impact of Henk Codrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henk Codrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henk Codrington more than expected).

Fields of papers citing papers by Henk Codrington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henk Codrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henk Codrington. The network helps show where Henk Codrington may publish in the future.

Co-authors

The 25 scholars most cited alongside Henk Codrington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henk Codrington Line = papers co-authored together Henk Codrington links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Roelof W. F. van Leeuwen, Robert Peric, Koen G. A. M. Hussaarts, Emma Kienhuis, Nikki S. IJzerman, Peter de Bruijn, Cor van der Leest, Henk Codrington, Jeroen S. Kloover, Bronno van der Holt, Joachim G.J.V. Aerts, Teun van Gelder, Ron H.J. Mathijssen	2016	94
2	Autofluorescence Bronchoscopy Improves Staging of Radiographically Occult Lung Cancer and Has an Impact on Therapeutic Strategy CHEST Journal ·Tom G. Sutedja, Henk Codrington, Elle K.J. Risse, R.H.J. Breuer, Johan C. van Mourik, Richard P. Golding, Pieter E. Postmus	2001	73
3	Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer Journal of Clinical Oncology ·Eva E. Schaake, Ingrid Kappers, Henk Codrington, Renato A. Valdés Olmos, Hendrik J. Teertstra, Renée van Pel, Jacobus A. Burgers, Harm van Tinteren, Houke M. Klomp	2012	68
4	Is ¹⁸F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non–Small Cell Lung Cancer? Journal of Nuclear Medicine ·Tjeerd S. Aukema, Ingrid Kappers, Renato A. Valdés Olmos, Henk Codrington, Harm van Tinteren, Renée van Pel, Houke M. Klomp, (unknown)	2010	66
5	Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab Radiotherapy and Oncology ·Iris Walraven, Michel M. van den Heuvel, Judi van Diessen, Eva Schaake, Wilma Uyterlinde, Joachim G.J.V. Aerts, Frederieke Koppe, Henk Codrington, Peter W.A. Kunst, Edith Dieleman, Paul van de Vaart, Marcel Verheij, J. Belderbos	2016	54
6	A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study Annals of Oncology ·Joachim G.J.V. Aerts, Henk Codrington, Nienke A. G. Lankheet, Sjaak A. Burgers, Bonne Biesma, Anne‐Marie C. Dingemans, Andrew Vincent, O. Dalesio, Harry J.M. Groen, Egbert F. Smit	2013	40
7	Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Efficacy and safety outcomes of a randomized, multi-center phase II study investigating Radiotherapy and Oncology ·Michel M. van den Heuvel, Wilma Uyterlinde, Andrew Vincent, Jeroen de Jong, Joachim G.J.V. Aerts, Frederike Koppe, J. Knegjens, Henk Codrington, Peter W.E. Kunst, Edith Dieleman, Marcel Verheij, J. Belderbos	2013	40
8	Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer Clinical Lung Cancer ·Karlijn J.G. Schulkes, Esteban T.D. Souwer, Leontine J. R. van Elden, Henk Codrington, Simone van der Sar–van der Brugge, Jan‐Willem J. Lammers, Johanneke E.A. Portielje, Frederiek van den Bos, Marije E. Hamaker	2017	34
9	The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer Lung ·Karlijn J.G. Schulkes, Esteban T.D. Souwer, Marije E. Hamaker, Henk Codrington, Simone van der Sar–van der Brugge, Jan‐Willem J. Lammers, Johanneke E.A. Portielje, Leontine J. R. van Elden, Frederiek van den Bos	2017	32
10	Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer Lung Cancer ·John W.G. van Putten, Paul Baas, Henk Codrington, Hian-Bie Kwa, Martín Müller, Neil K. Aaronson, Harry J.M. Groen	2001	28
11	18F-Fluorodeoxyglucose Positron Emission Tomography versus Computed Tomography in Predicting Histopathological Response to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor Treatment in Resectable Non-Small Cell Lung Cancer Annals of Surgical Oncology ·Matthijs H. van Gool, Tjeerd S. Aukema, Eva E. Schaake, Herman Rijna, Henk Codrington, Renato A. Valdés Olmos, Hendrik J. Teertstra, Renée van Pel, Sjaak A. Burgers, Harm van Tinteren, Houke M. Klomp	2014	24
12	Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy European Journal of Cancer ·J.H. Schouwink, Henk Codrington, H.P. Sleeboom, L.G.M. Kerkhofs, Lars W. Wormhoudt	2008	7
13	A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer BMC Cancer ·Hanieh Abedian Kalkhoran, J. Zwaveling, Bert N. Storm, Sylvia A. van Laar, Johanneke E.A. Portielje, Henk Codrington, Dieuwke Luijten, Pepijn Brocken, Egbert F. Smit, Loes E. Visser	2023	7
14	Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study Journal of Geriatric Oncology ·Bert N. Storm, Hanieh Abedian Kalkhoran, Erik B. Wilms, Pepijn Brocken, Henk Codrington, Danny Houtsma, Johanneke E. A. Portielje, Nienke A. de Glas, Daisy van der Ziel, Frederiek van den Bos, Loes E. Visser	2022	6
15	A randomized, multicenter phase II study investigating additional weekly cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Reporting on the efficacy. Journal of Clinical Oncology ·Michel M. van den Heuvel, Andrew Vincent, Wilma Uyterlinde, Joachim G.J.V. Aerts, F. Koppe, Henk Codrington, Peter W.E. Kunst, Edith Dieleman, Paul van de Vaart, Marcel Verheij, J. Belderbos	2012	5
16	Unusual Pulmonary Lesions Journal of Clinical Oncology ·Henk Codrington, Tom G. Sutedja, Richard P. Golding, Johan van Mourik, Elle K.J. Risse, Pieter E. Postmus	2002	2
17	A randomized phase II study of paclitaxel-carboplatin-bevacizumab (PCB) with or without nitroglycerin patches (NTG) in patients (pts) with stage IV nonsquamous non-small cell lung cancer (NSCLC): Nvalt 12 (NCT01171170). Journal of Clinical Oncology ·Anne‐Marie C. Dingemans, Harry J.M. Groen, Judith Herder, Jos A. Stigt, Egbert F. Smit, Idris Bahce, Otilia Dalesio, Sjaak A. Burgers, Henk Codrington, Ben van den Borne, Bonne Biesma, Andrew Vincent, Vincent van de Noort, Joachim G.J.V. Aerts	2014	2
18	A Randomized Phase II Study Comparing Erlotinib (E) Versus e Alternating with Chemotherapy in Relapsed Non-Small Cell Lung Cancer (NSCLC) Patients. The NVALT10 Study Annals of Oncology ·J.G. Aerts, Henk Codrington, Sjaak A. Burgers, Bonne Biesma, Otilia Dalesio, Anne‐Marie C. Dingemans, Andrew Vincent, Harry J.M. Groen, Egbert F. Smit	2012	2
19	OC-0498 CONCURRENT CHEMORADIOTHERAPY WITH OR WITHOUT CETUXIMAB IN NSCLC; TOXICITY RESULTS OF A RANDOMIZED PHASE II TRIAL Radiotherapy and Oncology ·J. Belderbos, Wilma Uyterlinde, A. Vincent, J.G. Aerts, Henk Codrington, Paul van de Vaart, Peter W.A. Kunst, Edith Dieleman, Marcel Verheij, Michel M. van den Heuvel	2012	2
20	Second-line treatment with single-agent gemcitabine (GEM) in patients (PTS) with advanced non-small-cell lung cancer (NSCLC) Lung Cancer ·J.W.G. van Putten, Paul Baas, Henk Codrington, H Kwa, Harry J.M. Groen	2000	1

About Henk Codrington

Henk Codrington is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Geriatrics and Gerontology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 587 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Diagnosis and Treatment (9 papers), Colorectal Cancer Treatments and Studies (6 papers), Lung Cancer Research Studies (6 papers), Medical Imaging Techniques and Applications (2 papers), Frailty in Older Adults (2 papers), Tracheal and airway disorders (2 papers) and Nutrition and Health in Aging (2 papers). The work is most often cited by research in Geriatrics and Gerontology (54 citations), Pulmonary and Respiratory Medicine (439 citations), Oncology (236 citations), Radiology, Nuclear Medicine and Imaging (117 citations) and Otorhinolaryngology (21 citations). Henk Codrington has collaborated with scholars based in Netherlands, United States and Malaysia. Frequent co-authors include Joachim G.J.V. Aerts, Harm van Tinteren, Renée van Pel, Renato A. Valdés Olmos, Houke M. Klomp, Ingrid Kappers, Elle K.J. Risse, Richard P. Golding, Pieter E. Postmus and Tom G. Sutedja. Their work appears in journals such as Journal of Clinical Oncology, Radiotherapy and Oncology, Lung Cancer, Annals of Oncology and Journal of Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Henk Codrington

Impact in

Papers in i

In The Last Decade

Henk Codrington

Peers

Countries citing papers authored by Henk Codrington

Fields of papers citing papers by Henk Codrington

All Works

About Henk Codrington

Explore authors with similar magnitude of impact

Papers in